Your browser doesn't support javascript.
loading
Prognostic value of the fluctuation in the neutrophil-lymphocyte ratio at 6 weeks of pembrolizumab treatment is specific to the clinical response in metastatic urothelial carcinoma.
Uchimoto, Taizo; Nakamura, Ko; Komura, Kazumasa; Fukuokaya, Wataru; Yano, Yusuke; Nishimura, Kazuki; Kinoshita, Shoko; Nishio, Kyosuke; Fukushima, Tatsuo; Nakamori, Keita; Matsunaga, Tomohisa; Tsutsumi, Takeshi; Tsujino, Takuya; Taniguchi, Kohei; Tanaka, Tomohito; Uehara, Hirofumi; Takahara, Kiyoshi; Inamoto, Teruo; Kimura, Takahiro; Egawa, Shin; Azuma, Haruhito.
Afiliação
  • Uchimoto T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Nakamura K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Komura K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan; Translational Research Program, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan. Electronic address: kazumasa.komura@ompu.ac.jp.
  • Fukuokaya W; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Yano Y; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Nishimura K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Kinoshita S; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Nishio K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Fukushima T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Nakamori K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Matsunaga T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Tsutsumi T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Tsujino T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Taniguchi K; Translational Research Program, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Tanaka T; Translational Research Program, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Uehara H; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Takahara K; Department of Urology, Fujita-Health University School of Medicine, Toyoake City, Aichi, Japan.
  • Inamoto T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
  • Kimura T; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan. Electronic address: tkimura0809@gmail.com.
  • Egawa S; Department of Urology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan.
  • Azuma H; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki City, Osaka, Japan.
Urol Oncol ; 40(7): 344.e11-344.e17, 2022 07.
Article em En | MEDLINE | ID: mdl-35346572
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article